Post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil as the new standard for graft-versus-host disease (GVHD) prophylaxis in reduced intensity conditioning: Results from phase III BMT CTN 1703 Meeting Abstract
| Authors: | Holtan, S. G.; Hamadani, M.; Wu, J.; Al Malki, M. M.; Runaas, L.; Elmariah, H.; Rezvani, A. R.; Gooptu, M.; Larkin, K. T.; Shaffer, B. C.; El Jurdi, N. H.; Loren, A. W.; Solh, M.; Hall, A. C.; Alousi, A. M.; Jamy, O. H.; Perales, M. A.; Yao, J. M.; Applegate, K.; Bhatt, A. S.; Kean, L. S.; Efebera, Y. A.; Kitko, C. L.; Reshef, R.; Clark, W.; DiFronzo, N. L.; Henderson, L.; Jones, R. J.; Liefer, E.; Martens, M. J.; Horowitz, M. M.; Bolanos-Meade, J. |
| Abstract Title: | Post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil as the new standard for graft-versus-host disease (GVHD) prophylaxis in reduced intensity conditioning: Results from phase III BMT CTN 1703 |
| Meeting Title: | 64rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-12-06 |
| Language: | English |
| ACCESSION: | WOS:000897957100005 |
| DOI: | 10.1182/blood-2022-171463 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA-4 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
